Display options
Cite
Chonkar AD, Managuli RS, Rao JV, et al. Development and validation of reversed phase high-performance liquid chromatography method for estimation of lercanidipine HCl in pure form and from nanosuspension formulation. J Basic Clin Pharm. 2015;7(1):17-22doi: 10.4103/0976-0105.170586.
Chonkar, A. D., Managuli, R. S., Rao, J. V., & Udupa, N. (2015). Development and validation of reversed phase high-performance liquid chromatography method for estimation of lercanidipine HCl in pure form and from nanosuspension formulation. Journal of basic and clinical pharmacy, 7(1), 17-22. https://doi.org/10.4103/0976-0105.170586
Chonkar, Ankita D, et al. "Development and validation of reversed phase high-performance liquid chromatography method for estimation of lercanidipine HCl in pure form and from nanosuspension formulation." Journal of basic and clinical pharmacy vol. 7,1 (2015): 17-22. doi: https://doi.org/10.4103/0976-0105.170586
Chonkar AD, Managuli RS, Rao JV, Udupa N. Development and validation of reversed phase high-performance liquid chromatography method for estimation of lercanidipine HCl in pure form and from nanosuspension formulation. J Basic Clin Pharm. 2015 Dec;7(1):17-22. doi: 10.4103/0976-0105.170586. PMID: 26792958; PMCID: PMC4702276.
Copy Download .nbib Format: NLM
Share it on

J Basic Clin Pharm. 2015 Dec;7(1):17-22. doi: 10.4103/0976-0105.170586.

Development and validation of reversed phase high-performance liquid chromatography method for estimation of lercanidipine HCl in pure form and from nanosuspension formulation.

Journal of basic and clinical pharmacy

Ankita D Chonkar, Renuka S Managuli, Josyula Venkata Rao, Nayanabhirama Udupa

Affiliations

  1. Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, India.
  2. Department of Pharm Biotechnology, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, India.
  3. Department of Pharmaceutical Management, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, India.

PMID: 26792958 PMCID: PMC4702276 DOI: 10.4103/0976-0105.170586

Abstract

AIM: Quantitative estimation of lercanidipine HCl in bulk material as well as from nanosuspension formulations via a developed reverse phase HPLC method.

MATERIALS AND METHODS: Optimized chromatographic condition was used to achieve separation on a Kromasil (100-5c18 250 × 4.6 mm) column using Shimadzu HPLC system. The mobile phase consisted of a mixture of acetate buffer (20 mM pH 4.5) and acetonitrile in the ratio of 10:90, v/v. It is pumped through the chromatographic system at a flow rate of 1 ml/min. The detection was carried out at 240 nm using ultraviolet-visible spectrophotometry detector. The method was validated as per Q2 (R1) guidelines, and suitability of the developed method was established by optimized nanosuspension formulation.

RESULTS: The method is specific to lercanidipine (RT: 7.7 min), and has ability to resolve the analyte peak from excipient interferences. It is linear (regression coefficient: 0.9993), accurate (average recovery: 100%), and passed all the system suitability requirements.

CONCLUSION: Developed method was found applicable for evaluation of drug content, content uniformity, and analyzing samples of dissolution studies of nanosuspension.

Keywords: Lercanidipine HCl; liquid chromatography; nanosuspension; validation

References

  1. Vasc Health Risk Manag. 2005;1(3):173-82 - PubMed
  2. J Pharm Biomed Anal. 2003 Feb 5;31(1):1-9 - PubMed
  3. Indian J Pharm Sci. 2010 May;72(3):381-4 - PubMed
  4. J Pharm Biomed Anal. 2003 Jul 14;32(3):441-50 - PubMed
  5. J Pharm Biomed Anal. 2004 Mar 10;34(5):979-87 - PubMed
  6. J Basic Clin Pharm. 2014 Dec;6(1):7-11 - PubMed

Publication Types